Literature DB >> 32895985

Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.

Christine J Ko1,2, Malini Harigopal2, Jeff R Gehlhausen1, Marcus Bosenberg1,2, Jennifer M McNiff1,2, William Damsky1,2.   

Abstract

BACKGROUND: Prior studies have shown the presence of immunohistochemical staining for the SARS-CoV-2 spike protein (SP) in endothelial cells and eccrine epithelium of acral perniosis classified as "COVID toes." Yet, other studies have been unable to detect SARS-CoV-2 RNA in skin biopsies of "COVID toes" by reverse-transcriptase polymerase chain reaction testing.
OBJECTIVE: In order to address these apparently conflicting findings, we compared detection of SARS-CoV-2 SP, through RNA in situ hybridization (ISH) vs immunohistochemistry (IHC), in skin biopsies of acral perniotic lesions presenting during the COVID-19 pandemic.
RESULTS: Three of six cases showed positive immunohistochemical labeling of endothelial cells, with one of three cases with sufficient depth also having labeling of eccrine glands, using an anti-SP SARS-CoV-2 antibody. These three cases positive with IHC were negative for SP by RNA ISH.
CONCLUSION: While the gold standard for detection of SARS-CoV-2 in tissue sections has yet to be determined, the detection of SARS-CoV-2 SP alone without spike RNA suggests that cleaved SP may be present in cutaneous endothelial cells and eccrine epithelium, providing a potential pathogenetic mechanism of COVID-19 endotheliitis.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; RNA in situ hybridization; SARS-CoV-2; coronavirus; spike protein

Mesh:

Substances:

Year:  2020        PMID: 32895985     DOI: 10.1111/cup.13866

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  18 in total

1.  Are 'COVID toes' actually caused by the coronavirus?

Authors:  Cassandra Willyard
Journal:  Nature       Date:  2022-03       Impact factor: 49.962

Review 2.  The skin as a critical window in unveiling the pathophysiologic principles of COVID-19.

Authors:  Cynthia Magro; Gerard Nuovo; J Justin Mulvey; Jeffrey Laurence; Joanna Harp; A Neil Crowson
Journal:  Clin Dermatol       Date:  2021-07-22       Impact factor: 3.541

3.  No antibody response in cutaneous manifestations associated with COVID-19: An observational study of 64 cases with microbiological and clinical characterization.

Authors:  Miguel Fernando García-Gil; Juan Monte-Serrano; Alejandro Lapeña-Casado; Pablo Villagrasa-Boli; Mar Ramírez-Lluch; Isabel Martínez-Pallás; Aura Bularca; Beatriz Aldea-Manrique; Rafael Benito-Ruesca; María Purificación Ventura-Faci; Mariano Ara-Martín
Journal:  Dermatol Ther       Date:  2021-10-08       Impact factor: 3.858

Review 4.  The pulmonary pathology of COVID-19.

Authors:  Hans Bösmüller; Matthias Matter; Falko Fend; Alexandar Tzankov
Journal:  Virchows Arch       Date:  2021-02-19       Impact factor: 4.064

5.  Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR.

Authors:  M F García-Gil; J Monte-Serrano; M García García; L Prieto-Torres; A J Pascual-Del-Riquelme; I Casas Flecha; M Ara-Martín
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-03-02       Impact factor: 9.228

6.  Endothelial cells are not productively infected by SARS-CoV-2.

Authors:  Lilian Schimmel; Keng Yih Chew; Claudia J Stocks; Teodor E Yordanov; Patricia Essebier; Arutha Kulasinghe; James Monkman; Anna Flavia Ribeiro Dos Santos Miggiolaro; Caroline Cooper; Lucia de Noronha; Kate Schroder; Anne Karine Lagendijk; Larisa I Labzin; Kirsty R Short; Emma J Gordon
Journal:  Clin Transl Immunology       Date:  2021-10-24

7.  SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions: reply from the authors.

Authors:  I Colmenero; C Santonja; M Alonso-Riaño; D Andina; J L Rodríguez Peralto; L Requena; A Torrelo
Journal:  Br J Dermatol       Date:  2020-12-16       Impact factor: 11.113

8.  Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers.

Authors:  Tsuguhisa Nakayama; Ivan T Lee; Sizun Jiang; Matthias S Matter; Carol H Yan; Jonathan B Overdevest; Chien-Ting Wu; Yury Goltsev; Liang-Chun Shih; Chun-Kang Liao; Bokai Zhu; Yunhao Bai; Peter Lidsky; Yinghong Xiao; David Zarabanda; Angela Yang; Meena Easwaran; Christian M Schürch; Pauline Chu; Han Chen; Anna K Stalder; David R McIlwain; Nicole A Borchard; Phillip A Gall; Sachi S Dholakia; Wei Le; Le Xu; Chih-Jaan Tai; Te-Huei Yeh; Elizabeth Erickson-Direnzo; Jason M Duran; Kirsten D Mertz; Peter H Hwang; Jasmin D Haslbauer; Peter K Jackson; Thomas Menter; Raul Andino; Peter D Canoll; Adam S DeConde; Zara M Patel; Alexandar Tzankov; Garry P Nolan; Jayakar V Nayak
Journal:  Cell Rep Med       Date:  2021-09-28

9.  Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR.

Authors:  Federica Zito Marino; Tiziana De Cristofaro; Massimo Varriale; Giuseppa Zannini; Andrea Ronchi; Elvira La Mantia; Carlo Pietro Campobasso; Francesco De Micco; Pasquale Mascolo; Maurizio Municinò; Emilia Municinò; Francesco Vestini; Omero Pinto; Marta Moccia; Noè De Stefano; Oscar Nappi; Carmen Sementa; Giovanni Zotti; Lamberto Pianese; Carmela Giordano; Renato Franco
Journal:  Virchows Arch       Date:  2022-02-01       Impact factor: 4.535

Review 10.  A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.

Authors:  Athanassios Kolivras; Curtis Thompson; Ievgenia Pastushenko; Marisa Mathieu; Pascal Bruderer; Marine de Vicq; Francesco Feoli; Saadia Harag; Isabelle Meiers; Catherine Olemans; Ursula Sass; Florence Dehavay; Ali Fakih; Xuan-Lan Lam-Hoai; Alice Marneffe; Laura Van De Borne; Valerie Vandersleyen; Bertrand Richert
Journal:  J Cutan Pathol       Date:  2021-08-09       Impact factor: 1.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.